Jefferies Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jefferies Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-132,300	Closed	-$14.5M	–	2185
2021 Q3	$14.5M	Buy	+132,300	New	+$13.7M	0.11%	173
2021 Q1	–	Sell	-55,800	Closed	-$4.08M	–	2177
2020 Q4	$4.08M	Buy	55,800 +44,400	+389%	+$3.3M	0.03%	474
2020 Q3	$886K	Buy	+11,400	New	+$784K	0.01%	841
2019 Q2	–	Sell	-85,000	Closed	-$2.25M	–	3065
2019 Q1	$2.25M	Buy	+85,000	New	+$2.01M	0.02%	856
2017 Q1	–	Sell	-248,400	Closed	-$4.02M	–	2798
2016 Q4	$4.02M	Buy	248,400 +186,500	+301%	+$3.38M	0.02%	657
2016 Q3	$1.12M	Buy	61,900 +4,300	+7%	+$84K	0.01%	1230
2016 Q2	$949K	Buy	57,600 +42,300	+276%	+$684K	﹤0.01%	1168
2016 Q1	$254K	Buy	+15,300	New	+$268K	﹤0.01%	1751
2015 Q3	–	Sell	-7,200	Closed	-$250K	–	3414
2015 Q2	$250K	Buy	+7,200	New	+$220K	﹤0.01%	1864
2015 Q1	–	Sell	-511,000	Closed	-$6.59M	–	2527
2014 Q4	$6.59M	Buy	+511,000	New	+$6.4M	0.04%	347
2014 Q3	–	Sell	-546,100	Closed	-$8.64M	–	2583
2014 Q2	$8.64M	Buy	546,100 +64,000	+13%	+$913K	0.07%	244
2014 Q1	$7.29M	Buy	+482,100	New	+$5.44M	0.07%	220

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jefferies Group's HZNP Position: Q3 2022 in Review

Jefferies Group increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 3,463% in Q3 2022, buying an estimated $16.1M and bringing the position to 237,185 shares worth $14.7M. The position accounts for 0.12% of the portfolio, ranked #125.

Jefferies Group first reported a position in HZNP in Q1 2014 and has held it in 24 quarters since. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Jefferies Group held 237,185 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $14.7M as of Q3 2022.
Jefferies Group bought 230,528 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $16.1M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.12% of Jefferies Group's portfolio in Q3 2022, its #125 holding.
Jefferies Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and has held it in 24 quarters since.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.